QURE – uniQure N.V.
Float Short %
19.32
Margin Of Safety %
Put/Call OI Ratio
0.2
EPS Next Q Diff
0.08
EPS Last/This Y
2.16
EPS This/Next Y
0.13
Price
15.69
Target Price
35.17
Analyst Recom
1.14
Performance Q
3.09
Relative Volume
0.9
Beta
0.12
Ticker: QURE
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | QURE | 15.1 | 0.21 | 0.72 | 47358 |
| 2025-07-28 | QURE | 15 | 0.21 | 9.32 | 47687 |
| 2025-07-29 | QURE | 13.67 | 0.23 | 0.08 | 48846 |
| 2025-07-30 | QURE | 14.45 | 0.17 | 0.21 | 64242 |
| 2025-07-31 | QURE | 13.92 | 0.17 | 0.05 | 64509 |
| 2025-08-01 | QURE | 13.67 | 0.17 | 0.39 | 64595 |
| 2025-08-04 | QURE | 13.77 | 0.17 | 0.38 | 64902 |
| 2025-08-05 | QURE | 14.02 | 0.17 | 0.04 | 64816 |
| 2025-08-06 | QURE | 13.49 | 0.17 | 1.38 | 64712 |
| 2025-08-07 | QURE | 13.44 | 0.19 | 0.21 | 65570 |
| 2025-08-08 | QURE | 13.27 | 0.19 | 0.11 | 65971 |
| 2025-08-11 | QURE | 14.14 | 0.19 | 3.86 | 66661 |
| 2025-08-12 | QURE | 14.31 | 0.21 | 1.56 | 67956 |
| 2025-08-13 | QURE | 14.59 | 0.21 | 0.50 | 68212 |
| 2025-08-14 | QURE | 15.8 | 0.21 | 1.53 | 68428 |
| 2025-08-15 | QURE | 16.19 | 0.24 | 0.79 | 69371 |
| 2025-08-18 | QURE | 15.68 | 0.19 | 0.49 | 49762 |
| 2025-08-19 | QURE | 15.34 | 0.20 | 0.06 | 49952 |
| 2025-08-20 | QURE | 15.49 | 0.20 | 0.22 | 49972 |
| 2025-08-21 | QURE | 15.47 | 0.20 | 0.31 | 51527 |
| 2025-08-22 | QURE | 15.68 | 0.20 | 2.95 | 53039 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | QURE | 15.11 | 28.9 | 36.2 | -2.96 |
| 2025-07-28 | QURE | 15.00 | 29.4 | 36.2 | -2.96 |
| 2025-07-29 | QURE | 13.68 | 29.4 | 52.2 | -2.96 |
| 2025-07-30 | QURE | 14.46 | 29.4 | 23.3 | -2.96 |
| 2025-07-31 | QURE | 13.92 | 29.4 | 24.6 | -2.96 |
| 2025-08-01 | QURE | 13.69 | 8.8 | 20.7 | -2.72 |
| 2025-08-04 | QURE | 13.77 | 8.8 | 16.3 | -2.72 |
| 2025-08-05 | QURE | 14.00 | 8.8 | 14.1 | -2.72 |
| 2025-08-06 | QURE | 13.48 | 8.8 | 24.7 | -2.72 |
| 2025-08-07 | QURE | 13.45 | 8.8 | 17.9 | -2.72 |
| 2025-08-08 | QURE | 13.28 | 8.8 | 19.8 | -2.72 |
| 2025-08-11 | QURE | 14.13 | 8.8 | 4.4 | -2.72 |
| 2025-08-12 | QURE | 14.31 | 8.8 | 14.9 | -2.72 |
| 2025-08-13 | QURE | 14.60 | 8.8 | 13.4 | -2.72 |
| 2025-08-14 | QURE | 15.78 | 8.8 | -3.1 | -2.72 |
| 2025-08-15 | QURE | 16.19 | 8.8 | 8.1 | -2.69 |
| 2025-08-18 | QURE | 15.67 | 7.1 | 19.0 | -2.76 |
| 2025-08-19 | QURE | 15.33 | 7.1 | 17.0 | -2.76 |
| 2025-08-20 | QURE | 15.49 | 7.1 | 11.0 | -2.76 |
| 2025-08-21 | QURE | 15.56 | 7.1 | 12.1 | -2.76 |
| 2025-08-22 | QURE | 15.69 | 7.1 | 11.2 | -2.76 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | QURE | -2.30 | 30.11 | 17.40 |
| 2025-07-28 | QURE | -2.30 | 29.53 | 17.40 |
| 2025-07-29 | QURE | -2.30 | 29.53 | 17.40 |
| 2025-07-30 | QURE | -2.30 | 29.53 | 17.40 |
| 2025-07-31 | QURE | -2.30 | 29.53 | 17.40 |
| 2025-08-01 | QURE | -2.29 | 29.53 | 17.36 |
| 2025-08-04 | QURE | -2.29 | 27.13 | 17.36 |
| 2025-08-05 | QURE | -2.29 | 27.13 | 17.36 |
| 2025-08-06 | QURE | -2.29 | 27.13 | 17.36 |
| 2025-08-07 | QURE | -2.29 | 27.13 | 17.36 |
| 2025-08-08 | QURE | -2.29 | 27.13 | 17.36 |
| 2025-08-11 | QURE | -2.29 | 26.93 | 17.36 |
| 2025-08-12 | QURE | -2.29 | 26.93 | 18.89 |
| 2025-08-13 | QURE | -2.29 | 26.93 | 18.89 |
| 2025-08-14 | QURE | -2.29 | 26.93 | 18.89 |
| 2025-08-15 | QURE | -2.29 | 26.93 | 18.89 |
| 2025-08-18 | QURE | -2.29 | 40.34 | 19.32 |
| 2025-08-19 | QURE | -1.89 | 40.34 | 19.32 |
| 2025-08-20 | QURE | -1.89 | 40.34 | 19.32 |
| 2025-08-21 | QURE | -1.89 | 40.34 | 19.32 |
| 2025-08-22 | QURE | -1.89 | 40.34 | 19.32 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.69
Avg. EPS Est. Current Quarter
-0.78
Avg. EPS Est. Next Quarter
-0.61
Insider Transactions
-1.89
Institutional Transactions
40.34
Beta
0.12
Average Sales Estimate Current Quarter
4
Average Sales Estimate Next Quarter
16
Fair Value
Quality Score
24
Growth Score
36
Sentiment Score
62
Actual DrawDown %
69.9
Max Drawdown 5-Year %
-92.5
Target Price
35.17
P/E
Forward P/E
PEG
P/S
60.07
P/B
P/Free Cash Flow
EPS
-3.92
Average EPS Est. Cur. Y
-2.76
EPS Next Y. (Est.)
-2.63
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1387.98
Relative Volume
0.9
Return on Equity vs Sector %
Return on Equity vs Industry %
EPS 1 7Days Diff
EPS 1 30Days Diff
0.2
EBIT Estimation
11.2
uniQure N.V.Sector: Healthcare
Industry: Biotechnology
Employees: 209
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
stock quote shares QURE – uniQure N.V. Stock Price stock today
news today QURE – uniQure N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch QURE – uniQure N.V. yahoo finance google finance
stock history QURE – uniQure N.V. invest stock market
stock prices QURE premarket after hours
ticker QURE fair value insiders trading